Description: The National Institutes of Health is seeking Wilson Wolf cell culture systems for patient cell therapy manufacturing for clinical trials. The opportunity is a competitive combined synopsis/solicitation for commercial products under NAICS 339113. It was posted on August 13, 2026, and responses are due by August 24, 2026, at 9:00 AM Eastern Time.
Federal · MD, US
Original attachments and procurement documents tied to this bid.
Federal RFP files are for Starbridge customers only.
You can request RFP files from all other buyer types for free on this site.
Adjacent opportunities open for bidding right now.
FederalMD
Aug 13, 2026
Closes
Aug 24, 2026
The National Institutes of Health is seeking Wilson Wolf cell culture systems for patient cell therapy manufacturing for clinical trials. The opportunity is a competitive combined synopsis/solicitation for commercial products under NAICS 339113. It was posted on August 13, 2026, and responses are due by August 24, 2026, at 9:00 AM Eastern Time.
Aug 26, 2026
Closes
Sep 23, 2026
Published August 5, 2026, this Phase II SBIR topic seeks a generalizable universal, species-agnostic cell-culture platform combining biological methods for establishing cells from arbitrary vertebrate and invertebrate species with autonomous closed-loop optimization and reproducible protocols. Proposers must address cross-species universality and autonomous culture automation, while gene-drive/genetic-biocontrol enablement is encouraged; any such work must remain in vitro/cellular, with no environmental release or gene-drive-competent whole organism. The official schedule lists an August 26, 2026 open date and a September 23, 2026 12:00 PM ET close, and DARPA's associated materials route selected proposers through contracting resources rather than presenting the opportunity as a grant announcement.
FederalMD
Aug 11, 2026
Closes
Aug 20, 2026
Reagents and consumable materials for cell therapy manufacturing.
Higher EducationIA
Aug 5, 2026
Closes
Aug 19, 2026
Provide 1 ea of bench-top bioreactor and cell culture system.
Procurement and program contacts connected to National Institutes of Health.
